Cutler Group LP Lantheus Holdings, Inc. Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$48.76 - $77.67 $307,188 - $489,321	-6,300 Reduced 68.48%	2,900 $0
Q3 2022 Oct 25, 2022	BUY	$61.42 - $86.29 $515,928 - $724,836	8,400 Added 1050.0%	9,200 $7,000
Q2 2022 Aug 04, 2022	BUY	$55.54 - $72.65 $38,878 - $50,855	700 Added 700.0%	800 $1,000
Q1 2022 Apr 14, 2022	BUY	$24.28 - $56.64 $2,428 - $5,664	100 New	100 $0
Q3 2021 Oct 26, 2021	SELL	$24.23 - $28.59 $2,423 - $2,859	-100 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$19.51 - $27.64 $11,706 - $16,584	-600 Reduced 85.71%	100 $0
Q4 2020 Jan 21, 2021	BUY	$10.75 - $14.91 $7,525 - $10,437	700 New	700 $0
Q1 2018 May 11, 2018	SELL	$14.85 - $24.3 $135,135 - $221,130	-9,100 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$17.4 - $23.4 $3,479 - $4,680	-200 Reduced 2.15%	9,100 $2,000
Q3 2017 Oct 17, 2017	BUY	$15.5 - $19.15 $144,150 - $178,095	9,300	9,300 $6,000

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.